Search results
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 14 hours agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 19 hours agoSanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...
Bristol Myers, Sanofi Liability in Hawaii Plavix Case Grows to $916 Million
Insurance Journal· 1 day agoA judge in Hawaii on Tuesday ordered Bristol Myers Squibb and Sanofi to pay more than $916 million...
Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To...
Benzinga via AOL· 1 day agoA judge in Hawaii has reportedly ordered Bristol Myers Squibb & Co (NYSE:BMY) and Sanofi SA...
Sanofi's Gold Bond named Official Body Skin Sponsor for Sports Illustrated Swimsuit Issue
NJBIZ· 4 days agoSanofi Consumer Healthcare-owned Gold Bold is the Official Body Skin Sponsor for the 60th...
Sanofi Drug Shows Promise in Asthma After Blood Disorder Success
Bloomberg· 2 days agoA Sanofi experimental drug showed promise in treating asthma, supporting the French drugmaker’s plan...
Q3 2024 EPS Estimates for Sanofi (NASDAQ:SNY) Increased by Analyst
ETF DAILY NEWS· 2 days agoSanofi (NASDAQ:SNY – Free Report) – Research analysts at Zacks Research raised their Q3 2024 EPS estimates for Sanofi in a report released ...
Sanofi enters partnership to enhance drug development using AI
Pharmaceutical Technology via Yahoo Finance· 2 days agoSanofi will offer extensive data, leveraging OpenAI's AI technology expertise and Formation Bio's...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The Motley Fool via AOL· 5 days agoThe agreement also features a non-exclusive license to Novavax's adjuvant technology for Sanofi's non-flu vaccines ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters· 4 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...